ZA951180B - Pharmaceutical compounds - Google Patents
Pharmaceutical compoundsInfo
- Publication number
- ZA951180B ZA951180B ZA951180A ZA951180A ZA951180B ZA 951180 B ZA951180 B ZA 951180B ZA 951180 A ZA951180 A ZA 951180A ZA 951180 A ZA951180 A ZA 951180A ZA 951180 B ZA951180 B ZA 951180B
- Authority
- ZA
- South Africa
- Prior art keywords
- pharmaceutical compounds
- pharmaceutical
- compounds
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
- C07D241/02—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB9402807A GB9402807D0 (en) | 1994-02-14 | 1994-02-14 | Pharmaceutical compounds |
Publications (1)
Publication Number | Publication Date |
---|---|
ZA951180B true ZA951180B (en) | 1996-08-14 |
Family
ID=10750355
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ZA951180A ZA951180B (en) | 1994-02-14 | 1995-02-14 | Pharmaceutical compounds |
Country Status (8)
Country | Link |
---|---|
EP (1) | EP0745070A1 (en) |
JP (1) | JPH09509157A (en) |
AU (1) | AU693159B2 (en) |
CA (1) | CA2182877A1 (en) |
GB (2) | GB9402807D0 (en) |
IL (1) | IL112624A0 (en) |
WO (1) | WO1995021832A1 (en) |
ZA (1) | ZA951180B (en) |
Families Citing this family (56)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IL112627A0 (en) * | 1994-02-14 | 1995-05-26 | Xenova Ltd | Diketopiperazines, their preparation and pharmaceutical or veterinary compositions containing them |
GB9426090D0 (en) * | 1994-12-23 | 1995-02-22 | Xenova Ltd | Pharmaceutical compounds |
GB9708805D0 (en) | 1997-05-01 | 1997-06-25 | Smithkline Beecham Plc | Compounds |
CN1261350A (en) | 1997-05-03 | 2000-07-26 | 史密丝克莱恩比彻姆有限公司 | Tetrahydroisoquinoline derivatives as modulators of dopamine D3 receptors |
EP2288166B1 (en) | 1997-06-09 | 2015-08-05 | Hitachi, Ltd. | Image decoding method |
GB9810876D0 (en) | 1998-05-20 | 1998-07-22 | Smithkline Beecham Plc | Compounds |
WO2000021951A1 (en) | 1998-10-08 | 2000-04-20 | Smithkline Beecham Plc | Tetrahydrobenzazepine derivatives useful as modulators of dopamine d3 receptors (antipsychotic agents) |
WO2001053290A1 (en) * | 2000-01-18 | 2001-07-26 | Nippon Steel Corporation | Cell division inhibitors and process for producing the same |
NZ522680A (en) * | 2000-05-09 | 2005-08-26 | Adpharma Inc | Piperazinedione compounds |
US7288545B2 (en) | 2000-05-09 | 2007-10-30 | Angiorx Corporation | Piperazinedione compounds |
ATE417614T1 (en) * | 2000-05-09 | 2009-01-15 | Angiorx Corp | PIPERAZINDIONE COMPOUNDS |
GB2372740A (en) * | 2001-01-17 | 2002-09-04 | Xenova Ltd | Diketopiperazines |
TW591020B (en) * | 2001-06-20 | 2004-06-11 | Wyeth Corp | 6-(aryl-amido or aryl-amidomethyl)-naphthalen-2-yloxy-acidic derivatives as inhibitors of plasminogen activator inhibitor type-1 (PAI-1) |
US7935704B2 (en) | 2003-08-01 | 2011-05-03 | Nereus Pharmaceuticals, Inc. | Dehydrophenylahistins and analogs thereof and the synthesis of dehydrophenylahistins and analogs thereof |
ATE374767T1 (en) * | 2002-08-02 | 2007-10-15 | Nereus Pharmaceuticals Inc | DEHYDROPHENYLAHISTINES AND ANALOGUES THEREOF AND A METHOD FOR PRODUCING DEHYDROPHENYLAHISTINES AND ANALOGUES THEREOF |
US7919497B2 (en) | 2002-08-02 | 2011-04-05 | Nereus Pharmaceuticals, Inc. | Analogs of dehydrophenylahistins and their therapeutic use |
NZ548659A (en) * | 2004-02-04 | 2011-01-28 | Nereus Pharmaceuticals Inc | Dehydrophenylahistins and analogs thereof and the synthesis of dehydrophenylahistins and analogs thereof |
TWI335816B (en) | 2004-05-26 | 2011-01-11 | Eisai R&D Man Co Ltd | Cinnamide compound |
EP1808432B1 (en) | 2004-10-26 | 2010-02-24 | Eisai R&D Management Co., Ltd. | Amorphous form of cinnamide compound |
TWI370130B (en) | 2005-11-24 | 2012-08-11 | Eisai R&D Man Co Ltd | Two cyclic cinnamide compound |
TWI378091B (en) | 2006-03-09 | 2012-12-01 | Eisai R&D Man Co Ltd | Multi-cyclic cinnamide derivatives |
US8044236B2 (en) | 2006-10-12 | 2011-10-25 | Institute Of Medicinal Molecular Design, Inc. | Carboxilic acid derivatives |
EP2072498A4 (en) | 2006-10-12 | 2012-07-18 | Inst Med Molecular Design Inc | N-phenyloxamidic acid derivative |
US8129527B2 (en) | 2006-11-03 | 2012-03-06 | Nereus Pharmacuticals, Inc. | Analogs of dehydrophenylahistins and their therapeutic use |
TW200848054A (en) | 2007-02-28 | 2008-12-16 | Eisai R&D Man Co Ltd | Two cyclic oxomorpholine derivatives |
AR068121A1 (en) | 2007-08-31 | 2009-11-04 | Eisai R&D Man Co Ltd | MULTICICLICAL COMPOUNDS TO TREAT NEURODEGENERATIVE DISEASES |
US7935815B2 (en) | 2007-08-31 | 2011-05-03 | Eisai R&D Management Co., Ltd. | Imidazoyl pyridine compounds and salts thereof |
KR20100097113A (en) | 2007-10-23 | 2010-09-02 | 가부시키가이샤 이야쿠 분지 셋케이 겐쿠쇼 | Pai-1 production inhibitor |
JPWO2009125606A1 (en) | 2008-04-11 | 2011-08-04 | 株式会社医薬分子設計研究所 | PAI-1 inhibitor |
JP2011530559A (en) * | 2008-08-13 | 2011-12-22 | ビーエーエスエフ ソシエタス・ヨーロピア | Process for preparing piperazinedione derivatives |
JP6678455B2 (en) * | 2012-12-21 | 2020-04-08 | エピザイム,インコーポレイティド | PRMT5 inhibitors and uses thereof |
CN105272968B (en) * | 2014-06-10 | 2018-03-13 | 首都医科大学 | The diketone of (3S, 6R) 3,6 disubstituted piperazine 2,5, it is prepared and application |
US10005792B2 (en) | 2014-09-03 | 2018-06-26 | Ctxt Pty. Ltd. | Aminoindane-, aminotetrahydronaphthalene- and aminobenzocyclobutane-derived PRMT5-inhibitors |
EP3189041B1 (en) | 2014-09-03 | 2021-04-28 | Ctxt Pty Ltd | Tetrahydroisoquinoline derived prmt5-inhibitors |
GB201415573D0 (en) | 2014-09-03 | 2014-10-15 | Cancer Therapeutics Crc Pty Ltd | Compounds |
MX2017011374A (en) | 2015-03-06 | 2018-01-23 | Beyondspring Pharmaceuticals Inc | Method of treating cancer associated with a ras mutation. |
MX2017011375A (en) | 2015-03-06 | 2018-01-23 | Beyondspring Pharmaceuticals Inc | Method of treating a brain tumor. |
CA2991059C (en) | 2015-07-13 | 2024-01-16 | Beyondspring Pharmaceuticals, Inc. | Plinabulin monohydrate polymorphs |
WO2017139231A1 (en) | 2016-02-08 | 2017-08-17 | Beyondspring Pharmaceuticals, Inc. | Compositions containing tucaresol or its analogs |
GB201604031D0 (en) | 2016-03-09 | 2016-04-20 | Ctxt Pty Ltd | Compounds |
GB201604027D0 (en) | 2016-03-09 | 2016-04-20 | Ctxt Pty Ltd | Compounds |
GB201604029D0 (en) | 2016-03-09 | 2016-04-20 | Ctxt Pty Ltd | Compounds |
GB201604030D0 (en) | 2016-03-09 | 2016-04-20 | Ctxt Pty Ltd | Compounds |
GB201604022D0 (en) | 2016-03-09 | 2016-04-20 | Ctxt Pty Ltd | Compounds |
GB201604020D0 (en) | 2016-03-09 | 2016-04-20 | Ctxt Pty Ltd | Compounds |
RU2760348C2 (en) | 2016-06-06 | 2021-11-24 | Бейондспринг Фармасьютикалс, Инк. | Method for reducing neutropenia |
CN106565686B (en) * | 2016-10-11 | 2019-03-01 | 深圳海王医药科技研究院有限公司 | Antitubulin |
CN110431135A (en) | 2017-01-06 | 2019-11-08 | 大连万春布林医药有限公司 | Tubulin binding compound and its therapeutical uses |
CA3052190A1 (en) | 2017-02-01 | 2018-08-09 | Beyondspring Pharmaceuticals, Inc. | Method of reducing neutropenia |
JP7065951B2 (en) | 2017-09-22 | 2022-05-12 | ジュビラント エピパッド エルエルシー | Heterocyclic compound as a PAD inhibitor |
WO2019077631A1 (en) | 2017-10-18 | 2019-04-25 | Jubilant Biosys Limited | Imidazo-pyridine compounds as pad inhibitors |
EP3707135A1 (en) | 2017-11-06 | 2020-09-16 | Jubilant Prodel LLC | Pyrimidine derivatives as inhibitors of pd1/pd-l1 activation |
EP3704120B1 (en) | 2017-11-24 | 2024-03-06 | Jubilant Episcribe LLC | Heterocyclic compounds as prmt5 inhibitors |
US11786523B2 (en) | 2018-01-24 | 2023-10-17 | Beyondspring Pharmaceuticals, Inc. | Composition and method for reducing thrombocytopenia |
KR20200131845A (en) | 2018-03-13 | 2020-11-24 | 주빌런트 프로델 엘엘씨 | Bicyclic compounds as inhibitors of PD1/PD-L1 interaction/activation |
CN116400068B (en) * | 2023-02-13 | 2023-09-22 | 泉州圣源警用侦察设备有限公司 | Reagent for revealing potential biological trace containing DNA and revealing method |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE621862C (en) * | 1932-07-01 | 1935-11-14 | Guenther Schiemann Dr | Process for the preparation of condensation products of nucleus fluorinated aryl aldehydes |
GB9217331D0 (en) * | 1992-08-14 | 1992-09-30 | Xenova Ltd | Pharmaceutical compounds |
JPH08247357A (en) * | 1995-03-13 | 1996-09-27 | Zexel Corp | Flange joint and forming method thereof |
-
1994
- 1994-02-14 GB GB9402807A patent/GB9402807D0/en active Pending
-
1995
- 1995-02-13 IL IL11262495A patent/IL112624A0/en unknown
- 1995-02-14 WO PCT/GB1995/000302 patent/WO1995021832A1/en not_active Application Discontinuation
- 1995-02-14 EP EP95908314A patent/EP0745070A1/en not_active Withdrawn
- 1995-02-14 GB GB9502874A patent/GB2286395B/en not_active Expired - Fee Related
- 1995-02-14 ZA ZA951180A patent/ZA951180B/en unknown
- 1995-02-14 CA CA002182877A patent/CA2182877A1/en not_active Abandoned
- 1995-02-14 JP JP7521082A patent/JPH09509157A/en not_active Ceased
- 1995-02-14 AU AU16677/95A patent/AU693159B2/en not_active Ceased
Also Published As
Publication number | Publication date |
---|---|
WO1995021832A1 (en) | 1995-08-17 |
AU1667795A (en) | 1995-08-29 |
IL112624A0 (en) | 1995-05-26 |
GB9402807D0 (en) | 1994-04-06 |
JPH09509157A (en) | 1997-09-16 |
GB9502874D0 (en) | 1995-04-05 |
GB2286395B (en) | 1998-08-26 |
EP0745070A1 (en) | 1996-12-04 |
AU693159B2 (en) | 1998-06-25 |
CA2182877A1 (en) | 1995-08-17 |
GB2286395A (en) | 1995-08-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB9502874D0 (en) | Pharmaceutical compounds | |
ZA959921B (en) | Pharmaceutical compounds | |
GB9602080D0 (en) | Pharmaceutical compounds | |
ZA954226B (en) | Pharmaceutical compounds | |
GB9502861D0 (en) | Pharmaceutical compounds | |
GB2286394B (en) | Pharmaceutical compounds | |
ZA9510909B (en) | Pharmaceutical compounds | |
GB9609976D0 (en) | Pharmaceutical compounds | |
GB9418326D0 (en) | Pharmaceutical compounds | |
GB9417102D0 (en) | Pharmaceutical compounds | |
EP0923564A4 (en) | Pharmaceutical compounds | |
ZA9510903B (en) | Pharmaceutical compounds | |
GB9426080D0 (en) | Pharmaceutical compounds | |
ZA951175B (en) | Pharmaceutical compounds | |
ZA956419B (en) | Pharmaceutical compound | |
GB9402889D0 (en) | Pharmaceutical compounds | |
GB9426092D0 (en) | Pharmaceutical compounds | |
GB9402806D0 (en) | Pharmaceutical compounds | |
ZA944689B (en) | Pharmaceutical compounds | |
ZA941781B (en) | Pharmaceutical compounds | |
SG32534A1 (en) | Pharmaceutical compounds | |
SG32533A1 (en) | Pharmaceutical compounds | |
GB9406052D0 (en) | Pharmaceutical compounds | |
GB9417514D0 (en) | Pharmaceutical compounds | |
GB9425040D0 (en) | Pharmaceutical compounds |